Finance

Lists
EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹ २,३४८.९०
-०.५४%
(-१२.८०) 1D
नोभेम्बर १६, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for EMCURE...
Open
₹ २,३५०.००
High
₹ २,३८९.८०
Low
₹ २,३२६.६०
Mkt. cap
४.४५ खरब
Avg. vol.
२.२८ लाख
Volume
१.०५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.३१
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
Open
₹ २,३५०.००
High
₹ २,३८९.८०
Low
₹ २,३२६.६०
Mkt. cap
४.४५ खरब
Avg. vol.
२.२८ लाख
Volume
१.०५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.३१
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
News stories
From web sources and news partners
StreetInsider
StreetInsider
·
९ मिनेट पहिले
VEON outlines 2030 growth targets at capital markets day
Opening Bell Daily
Opening Bell Daily
·
२५ मिनेट पहिले
Berkshire stock: beat the S&P 500 in every dot-com bust year
富途牛牛
富途牛牛
·
८ मिनेट पहिले
How to Use Options to Bet Against Big Tech, While Keeping Risk in Check
The Washington Post
The Washington Post
·
१३ मिनेट पहिले
Nearly a fifth of the S&P 500 is tied to three men with no clear successors
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees६.९१ हजार
Founded१९८१ अप्रिल १६
Headquarters-
SectorHealth Care
Industry-
Websiteemcure.com
Last report
२०२६ नोभेम्बर ३
Fiscal period
Q2 2027
₹ १७.१४ / ₹ १४.९०
+१५.०३%beat
Revenue / Est. (INR)
२८.२० अरब / २६.५२ अरब
+६.३५%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
२३.६३ अरब
२४.७० अरब
२५.८० अरब
२८.२० अरब
Cost of goods sold
९.६२ अरब
१०.९३ अरब
१०.७३ अरब
११.४२ अरब
Cost of revenue
९.६२ अरब
१०.९३ अरब
१०.७३ अरब
११.४२ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.८७ अरब
७.२१ अरब
४.०९ अरब
४.३५ अरब
Operating expense
१०.४६ अरब
९.९७ अरब
११.०९ अरब
१२.१३ अरब
Total operating expenses
२०.०८ अरब
२०.९० अरब
२१.८२ अरब
२३.५५ अरब
Operating income
३.५५ अरब
३.७९ अरब
३.९८ अरब
४.६५ अरब
Other non operating income
१.८५ करोड
-३६.३७ करोड
२.०७ करोड
३.२५ करोड
EBT including unusual items
३.१४ अरब
३.४१ अरब
३.९४ अरब
४.४६ अरब
EBT excluding unusual items
३.५२ अरब
३.७२ अरब
३.९२ अरब
४.४६ अरब
Income tax expense
८२.४२ करोड
९७.४४ करोड
१.०१ अरब
१.२१ अरब
Effective tax rate
२६.२७%
२८.५६%
२५.६७%
२७.०९%
Other operating expenses
५.५४ अरब
१.७० अरब
५.९० अरब
६.६९ अरब
Net income
२.३१ अरब
२.४३ अरब
२.९४ अरब
३.२६ अरब
Net profit margin
९.७५%
९.८६%
११.३९%
११.५४%
Earnings per share
१३.६७
१४.७०
१५.३४
१७.१४
Interest and investment income
-
१.६८ करोड
-
-
Interest expense
-३७.९८ करोड
-९.२५ करोड
-३१.५४ करोड
-३५.५८ करोड
Net interest expenses
-३७.९८ करोड
-७.५७ करोड
-३१.५४ करोड
-३५.५८ करोड
Depreciation and amortization charges
१.०५ अरब
१.०६ अरब
१.१० अरब
१.१० अरब
EBITDA
४.३७ अरब
४.६७ अरब
५.०२ अरब
५.७५ अरब
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू